Global Antisense Oligonucleotides (ASO) Drug Market Research Report 2024(Status and Outlook)
Report Overview
Antisense oligonucleotide (ASO) drugs are small, synthetic single-stranded nucleic acid polymers that can be used to regulate gene expression through a variety of mechanisms.
This report provides a deep insight into the global Antisense Oligonucleotides (ASO) Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antisense Oligonucleotides (ASO) Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antisense Oligonucleotides (ASO) Drug market in any manner.
Global Antisense Oligonucleotides (ASO) Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Ionis
Novartis
Biogen
Akcea
Therapeutics
Sarepta Therapeutics
WAVElife
ProQR
Exicure
Secarna
AstraZeneca
The WhiteOak Group, Inc.
Dicerna
Silence
Arrowhead
Alnylam
Market Segmentation (by Type)
Fomivirsen
Spinraza
Tegsedi
Waylivra
Vyondys 53
Market Segmentation (by Application)
Single Gene Rare Disease
Protein Deposition Disease
Chronic Liver Disease
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antisense Oligonucleotides (ASO) Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Antisense oligonucleotide (ASO) drugs are small, synthetic single-stranded nucleic acid polymers that can be used to regulate gene expression through a variety of mechanisms.
This report provides a deep insight into the global Antisense Oligonucleotides (ASO) Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Antisense Oligonucleotides (ASO) Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Antisense Oligonucleotides (ASO) Drug market in any manner.
Global Antisense Oligonucleotides (ASO) Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Ionis
Novartis
Biogen
Akcea
Therapeutics
Sarepta Therapeutics
WAVElife
ProQR
Exicure
Secarna
AstraZeneca
The WhiteOak Group, Inc.
Dicerna
Silence
Arrowhead
Alnylam
Market Segmentation (by Type)
Fomivirsen
Spinraza
Tegsedi
Waylivra
Vyondys 53
Market Segmentation (by Application)
Single Gene Rare Disease
Protein Deposition Disease
Chronic Liver Disease
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Antisense Oligonucleotides (ASO) Drug Market
- Overview of the regional outlook of the Antisense Oligonucleotides (ASO) Drug Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Antisense Oligonucleotides (ASO) Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Antisense Oligonucleotides (ASO) Drug
1.2 Key Market Segments
1.2.1 Antisense Oligonucleotides (ASO) Drug Segment by Type
1.2.2 Antisense Oligonucleotides (ASO) Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Antisense Oligonucleotides (ASO) Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Antisense Oligonucleotides (ASO) Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Antisense Oligonucleotides (ASO) Drug Sales by Manufacturers (2019-2024)
3.2 Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Antisense Oligonucleotides (ASO) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antisense Oligonucleotides (ASO) Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Antisense Oligonucleotides (ASO) Drug Sales Sites, Area Served, Product Type
3.6 Antisense Oligonucleotides (ASO) Drug Market Competitive Situation and Trends
3.6.1 Antisense Oligonucleotides (ASO) Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antisense Oligonucleotides (ASO) Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG INDUSTRY CHAIN ANALYSIS
4.1 Antisense Oligonucleotides (ASO) Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Type (2019-2024)
6.3 Global Antisense Oligonucleotides (ASO) Drug Market Size Market Share by Type (2019-2024)
6.4 Global Antisense Oligonucleotides (ASO) Drug Price by Type (2019-2024)
7 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antisense Oligonucleotides (ASO) Drug Market Sales by Application (2019-2024)
7.3 Global Antisense Oligonucleotides (ASO) Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Antisense Oligonucleotides (ASO) Drug Sales Growth Rate by Application (2019-2024)
8 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG MARKET SEGMENTATION BY REGION
8.1 Global Antisense Oligonucleotides (ASO) Drug Sales by Region
8.1.1 Global Antisense Oligonucleotides (ASO) Drug Sales by Region
8.1.2 Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Antisense Oligonucleotides (ASO) Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antisense Oligonucleotides (ASO) Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antisense Oligonucleotides (ASO) Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antisense Oligonucleotides (ASO) Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antisense Oligonucleotides (ASO) Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Ionis
9.1.1 Ionis Antisense Oligonucleotides (ASO) Drug Basic Information
9.1.2 Ionis Antisense Oligonucleotides (ASO) Drug Product Overview
9.1.3 Ionis Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.1.4 Ionis Business Overview
9.1.5 Ionis Antisense Oligonucleotides (ASO) Drug SWOT Analysis
9.1.6 Ionis Recent Developments
9.2 Novartis
9.2.1 Novartis Antisense Oligonucleotides (ASO) Drug Basic Information
9.2.2 Novartis Antisense Oligonucleotides (ASO) Drug Product Overview
9.2.3 Novartis Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Antisense Oligonucleotides (ASO) Drug SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Biogen
9.3.1 Biogen Antisense Oligonucleotides (ASO) Drug Basic Information
9.3.2 Biogen Antisense Oligonucleotides (ASO) Drug Product Overview
9.3.3 Biogen Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.3.4 Biogen Antisense Oligonucleotides (ASO) Drug SWOT Analysis
9.3.5 Biogen Business Overview
9.3.6 Biogen Recent Developments
9.4 Akcea
9.4.1 Akcea Antisense Oligonucleotides (ASO) Drug Basic Information
9.4.2 Akcea Antisense Oligonucleotides (ASO) Drug Product Overview
9.4.3 Akcea Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.4.4 Akcea Business Overview
9.4.5 Akcea Recent Developments
9.5 Therapeutics
9.5.1 Therapeutics Antisense Oligonucleotides (ASO) Drug Basic Information
9.5.2 Therapeutics Antisense Oligonucleotides (ASO) Drug Product Overview
9.5.3 Therapeutics Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.5.4 Therapeutics Business Overview
9.5.5 Therapeutics Recent Developments
9.6 Sarepta Therapeutics
9.6.1 Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Basic Information
9.6.2 Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Product Overview
9.6.3 Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.6.4 Sarepta Therapeutics Business Overview
9.6.5 Sarepta Therapeutics Recent Developments
9.7 WAVElife
9.7.1 WAVElife Antisense Oligonucleotides (ASO) Drug Basic Information
9.7.2 WAVElife Antisense Oligonucleotides (ASO) Drug Product Overview
9.7.3 WAVElife Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.7.4 WAVElife Business Overview
9.7.5 WAVElife Recent Developments
9.8 ProQR
9.8.1 ProQR Antisense Oligonucleotides (ASO) Drug Basic Information
9.8.2 ProQR Antisense Oligonucleotides (ASO) Drug Product Overview
9.8.3 ProQR Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.8.4 ProQR Business Overview
9.8.5 ProQR Recent Developments
9.9 Exicure
9.9.1 Exicure Antisense Oligonucleotides (ASO) Drug Basic Information
9.9.2 Exicure Antisense Oligonucleotides (ASO) Drug Product Overview
9.9.3 Exicure Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.9.4 Exicure Business Overview
9.9.5 Exicure Recent Developments
9.10 Secarna
9.10.1 Secarna Antisense Oligonucleotides (ASO) Drug Basic Information
9.10.2 Secarna Antisense Oligonucleotides (ASO) Drug Product Overview
9.10.3 Secarna Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.10.4 Secarna Business Overview
9.10.5 Secarna Recent Developments
9.11 AstraZeneca
9.11.1 AstraZeneca Antisense Oligonucleotides (ASO) Drug Basic Information
9.11.2 AstraZeneca Antisense Oligonucleotides (ASO) Drug Product Overview
9.11.3 AstraZeneca Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.11.4 AstraZeneca Business Overview
9.11.5 AstraZeneca Recent Developments
9.12 The WhiteOak Group, Inc.
9.12.1 The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Basic Information
9.12.2 The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Product Overview
9.12.3 The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.12.4 The WhiteOak Group, Inc. Business Overview
9.12.5 The WhiteOak Group, Inc. Recent Developments
9.13 Dicerna
9.13.1 Dicerna Antisense Oligonucleotides (ASO) Drug Basic Information
9.13.2 Dicerna Antisense Oligonucleotides (ASO) Drug Product Overview
9.13.3 Dicerna Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.13.4 Dicerna Business Overview
9.13.5 Dicerna Recent Developments
9.14 Silence
9.14.1 Silence Antisense Oligonucleotides (ASO) Drug Basic Information
9.14.2 Silence Antisense Oligonucleotides (ASO) Drug Product Overview
9.14.3 Silence Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.14.4 Silence Business Overview
9.14.5 Silence Recent Developments
9.15 Arrowhead
9.15.1 Arrowhead Antisense Oligonucleotides (ASO) Drug Basic Information
9.15.2 Arrowhead Antisense Oligonucleotides (ASO) Drug Product Overview
9.15.3 Arrowhead Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.15.4 Arrowhead Business Overview
9.15.5 Arrowhead Recent Developments
9.16 Alnylam
9.16.1 Alnylam Antisense Oligonucleotides (ASO) Drug Basic Information
9.16.2 Alnylam Antisense Oligonucleotides (ASO) Drug Product Overview
9.16.3 Alnylam Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.16.4 Alnylam Business Overview
9.16.5 Alnylam Recent Developments
10 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG MARKET FORECAST BY REGION
10.1 Global Antisense Oligonucleotides (ASO) Drug Market Size Forecast
10.2 Global Antisense Oligonucleotides (ASO) Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Country
10.2.3 Asia Pacific Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Region
10.2.4 South America Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Antisense Oligonucleotides (ASO) Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Antisense Oligonucleotides (ASO) Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Antisense Oligonucleotides (ASO) Drug by Type (2025-2030)
11.1.2 Global Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Antisense Oligonucleotides (ASO) Drug by Type (2025-2030)
11.2 Global Antisense Oligonucleotides (ASO) Drug Market Forecast by Application (2025-2030)
11.2.1 Global Antisense Oligonucleotides (ASO) Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Antisense Oligonucleotides (ASO) Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Antisense Oligonucleotides (ASO) Drug
1.2 Key Market Segments
1.2.1 Antisense Oligonucleotides (ASO) Drug Segment by Type
1.2.2 Antisense Oligonucleotides (ASO) Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Antisense Oligonucleotides (ASO) Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Antisense Oligonucleotides (ASO) Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Antisense Oligonucleotides (ASO) Drug Sales by Manufacturers (2019-2024)
3.2 Global Antisense Oligonucleotides (ASO) Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Antisense Oligonucleotides (ASO) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Antisense Oligonucleotides (ASO) Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Antisense Oligonucleotides (ASO) Drug Sales Sites, Area Served, Product Type
3.6 Antisense Oligonucleotides (ASO) Drug Market Competitive Situation and Trends
3.6.1 Antisense Oligonucleotides (ASO) Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Antisense Oligonucleotides (ASO) Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG INDUSTRY CHAIN ANALYSIS
4.1 Antisense Oligonucleotides (ASO) Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Type (2019-2024)
6.3 Global Antisense Oligonucleotides (ASO) Drug Market Size Market Share by Type (2019-2024)
6.4 Global Antisense Oligonucleotides (ASO) Drug Price by Type (2019-2024)
7 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Antisense Oligonucleotides (ASO) Drug Market Sales by Application (2019-2024)
7.3 Global Antisense Oligonucleotides (ASO) Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Antisense Oligonucleotides (ASO) Drug Sales Growth Rate by Application (2019-2024)
8 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG MARKET SEGMENTATION BY REGION
8.1 Global Antisense Oligonucleotides (ASO) Drug Sales by Region
8.1.1 Global Antisense Oligonucleotides (ASO) Drug Sales by Region
8.1.2 Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Antisense Oligonucleotides (ASO) Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Antisense Oligonucleotides (ASO) Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Antisense Oligonucleotides (ASO) Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Antisense Oligonucleotides (ASO) Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Antisense Oligonucleotides (ASO) Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Ionis
9.1.1 Ionis Antisense Oligonucleotides (ASO) Drug Basic Information
9.1.2 Ionis Antisense Oligonucleotides (ASO) Drug Product Overview
9.1.3 Ionis Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.1.4 Ionis Business Overview
9.1.5 Ionis Antisense Oligonucleotides (ASO) Drug SWOT Analysis
9.1.6 Ionis Recent Developments
9.2 Novartis
9.2.1 Novartis Antisense Oligonucleotides (ASO) Drug Basic Information
9.2.2 Novartis Antisense Oligonucleotides (ASO) Drug Product Overview
9.2.3 Novartis Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.2.4 Novartis Business Overview
9.2.5 Novartis Antisense Oligonucleotides (ASO) Drug SWOT Analysis
9.2.6 Novartis Recent Developments
9.3 Biogen
9.3.1 Biogen Antisense Oligonucleotides (ASO) Drug Basic Information
9.3.2 Biogen Antisense Oligonucleotides (ASO) Drug Product Overview
9.3.3 Biogen Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.3.4 Biogen Antisense Oligonucleotides (ASO) Drug SWOT Analysis
9.3.5 Biogen Business Overview
9.3.6 Biogen Recent Developments
9.4 Akcea
9.4.1 Akcea Antisense Oligonucleotides (ASO) Drug Basic Information
9.4.2 Akcea Antisense Oligonucleotides (ASO) Drug Product Overview
9.4.3 Akcea Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.4.4 Akcea Business Overview
9.4.5 Akcea Recent Developments
9.5 Therapeutics
9.5.1 Therapeutics Antisense Oligonucleotides (ASO) Drug Basic Information
9.5.2 Therapeutics Antisense Oligonucleotides (ASO) Drug Product Overview
9.5.3 Therapeutics Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.5.4 Therapeutics Business Overview
9.5.5 Therapeutics Recent Developments
9.6 Sarepta Therapeutics
9.6.1 Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Basic Information
9.6.2 Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Product Overview
9.6.3 Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.6.4 Sarepta Therapeutics Business Overview
9.6.5 Sarepta Therapeutics Recent Developments
9.7 WAVElife
9.7.1 WAVElife Antisense Oligonucleotides (ASO) Drug Basic Information
9.7.2 WAVElife Antisense Oligonucleotides (ASO) Drug Product Overview
9.7.3 WAVElife Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.7.4 WAVElife Business Overview
9.7.5 WAVElife Recent Developments
9.8 ProQR
9.8.1 ProQR Antisense Oligonucleotides (ASO) Drug Basic Information
9.8.2 ProQR Antisense Oligonucleotides (ASO) Drug Product Overview
9.8.3 ProQR Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.8.4 ProQR Business Overview
9.8.5 ProQR Recent Developments
9.9 Exicure
9.9.1 Exicure Antisense Oligonucleotides (ASO) Drug Basic Information
9.9.2 Exicure Antisense Oligonucleotides (ASO) Drug Product Overview
9.9.3 Exicure Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.9.4 Exicure Business Overview
9.9.5 Exicure Recent Developments
9.10 Secarna
9.10.1 Secarna Antisense Oligonucleotides (ASO) Drug Basic Information
9.10.2 Secarna Antisense Oligonucleotides (ASO) Drug Product Overview
9.10.3 Secarna Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.10.4 Secarna Business Overview
9.10.5 Secarna Recent Developments
9.11 AstraZeneca
9.11.1 AstraZeneca Antisense Oligonucleotides (ASO) Drug Basic Information
9.11.2 AstraZeneca Antisense Oligonucleotides (ASO) Drug Product Overview
9.11.3 AstraZeneca Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.11.4 AstraZeneca Business Overview
9.11.5 AstraZeneca Recent Developments
9.12 The WhiteOak Group, Inc.
9.12.1 The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Basic Information
9.12.2 The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Product Overview
9.12.3 The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.12.4 The WhiteOak Group, Inc. Business Overview
9.12.5 The WhiteOak Group, Inc. Recent Developments
9.13 Dicerna
9.13.1 Dicerna Antisense Oligonucleotides (ASO) Drug Basic Information
9.13.2 Dicerna Antisense Oligonucleotides (ASO) Drug Product Overview
9.13.3 Dicerna Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.13.4 Dicerna Business Overview
9.13.5 Dicerna Recent Developments
9.14 Silence
9.14.1 Silence Antisense Oligonucleotides (ASO) Drug Basic Information
9.14.2 Silence Antisense Oligonucleotides (ASO) Drug Product Overview
9.14.3 Silence Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.14.4 Silence Business Overview
9.14.5 Silence Recent Developments
9.15 Arrowhead
9.15.1 Arrowhead Antisense Oligonucleotides (ASO) Drug Basic Information
9.15.2 Arrowhead Antisense Oligonucleotides (ASO) Drug Product Overview
9.15.3 Arrowhead Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.15.4 Arrowhead Business Overview
9.15.5 Arrowhead Recent Developments
9.16 Alnylam
9.16.1 Alnylam Antisense Oligonucleotides (ASO) Drug Basic Information
9.16.2 Alnylam Antisense Oligonucleotides (ASO) Drug Product Overview
9.16.3 Alnylam Antisense Oligonucleotides (ASO) Drug Product Market Performance
9.16.4 Alnylam Business Overview
9.16.5 Alnylam Recent Developments
10 ANTISENSE OLIGONUCLEOTIDES (ASO) DRUG MARKET FORECAST BY REGION
10.1 Global Antisense Oligonucleotides (ASO) Drug Market Size Forecast
10.2 Global Antisense Oligonucleotides (ASO) Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Country
10.2.3 Asia Pacific Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Region
10.2.4 South America Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Antisense Oligonucleotides (ASO) Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Antisense Oligonucleotides (ASO) Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Antisense Oligonucleotides (ASO) Drug by Type (2025-2030)
11.1.2 Global Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Antisense Oligonucleotides (ASO) Drug by Type (2025-2030)
11.2 Global Antisense Oligonucleotides (ASO) Drug Market Forecast by Application (2025-2030)
11.2.1 Global Antisense Oligonucleotides (ASO) Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Antisense Oligonucleotides (ASO) Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Antisense Oligonucleotides (ASO) Drug Market Size Comparison by Region (M USD)
Table 5. Global Antisense Oligonucleotides (ASO) Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Antisense Oligonucleotides (ASO) Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Antisense Oligonucleotides (ASO) Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotides (ASO) Drug as of 2022)
Table 10. Global Market Antisense Oligonucleotides (ASO) Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Antisense Oligonucleotides (ASO) Drug Sales Sites and Area Served
Table 12. Manufacturers Antisense Oligonucleotides (ASO) Drug Product Type
Table 13. Global Antisense Oligonucleotides (ASO) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Antisense Oligonucleotides (ASO) Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antisense Oligonucleotides (ASO) Drug Market Challenges
Table 22. Global Antisense Oligonucleotides (ASO) Drug Sales by Type (Kilotons)
Table 23. Global Antisense Oligonucleotides (ASO) Drug Market Size by Type (M USD)
Table 24. Global Antisense Oligonucleotides (ASO) Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Type (2019-2024)
Table 26. Global Antisense Oligonucleotides (ASO) Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Antisense Oligonucleotides (ASO) Drug Market Size Share by Type (2019-2024)
Table 28. Global Antisense Oligonucleotides (ASO) Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Antisense Oligonucleotides (ASO) Drug Sales (Kilotons) by Application
Table 30. Global Antisense Oligonucleotides (ASO) Drug Market Size by Application
Table 31. Global Antisense Oligonucleotides (ASO) Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Application (2019-2024)
Table 33. Global Antisense Oligonucleotides (ASO) Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Antisense Oligonucleotides (ASO) Drug Market Share by Application (2019-2024)
Table 35. Global Antisense Oligonucleotides (ASO) Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Antisense Oligonucleotides (ASO) Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Region (2019-2024)
Table 38. North America Antisense Oligonucleotides (ASO) Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Antisense Oligonucleotides (ASO) Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Antisense Oligonucleotides (ASO) Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Antisense Oligonucleotides (ASO) Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Antisense Oligonucleotides (ASO) Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Ionis Antisense Oligonucleotides (ASO) Drug Basic Information
Table 44. Ionis Antisense Oligonucleotides (ASO) Drug Product Overview
Table 45. Ionis Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Ionis Business Overview
Table 47. Ionis Antisense Oligonucleotides (ASO) Drug SWOT Analysis
Table 48. Ionis Recent Developments
Table 49. Novartis Antisense Oligonucleotides (ASO) Drug Basic Information
Table 50. Novartis Antisense Oligonucleotides (ASO) Drug Product Overview
Table 51. Novartis Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Novartis Business Overview
Table 53. Novartis Antisense Oligonucleotides (ASO) Drug SWOT Analysis
Table 54. Novartis Recent Developments
Table 55. Biogen Antisense Oligonucleotides (ASO) Drug Basic Information
Table 56. Biogen Antisense Oligonucleotides (ASO) Drug Product Overview
Table 57. Biogen Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Biogen Antisense Oligonucleotides (ASO) Drug SWOT Analysis
Table 59. Biogen Business Overview
Table 60. Biogen Recent Developments
Table 61. Akcea Antisense Oligonucleotides (ASO) Drug Basic Information
Table 62. Akcea Antisense Oligonucleotides (ASO) Drug Product Overview
Table 63. Akcea Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Akcea Business Overview
Table 65. Akcea Recent Developments
Table 66. Therapeutics Antisense Oligonucleotides (ASO) Drug Basic Information
Table 67. Therapeutics Antisense Oligonucleotides (ASO) Drug Product Overview
Table 68. Therapeutics Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Therapeutics Business Overview
Table 70. Therapeutics Recent Developments
Table 71. Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Basic Information
Table 72. Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Product Overview
Table 73. Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Sarepta Therapeutics Business Overview
Table 75. Sarepta Therapeutics Recent Developments
Table 76. WAVElife Antisense Oligonucleotides (ASO) Drug Basic Information
Table 77. WAVElife Antisense Oligonucleotides (ASO) Drug Product Overview
Table 78. WAVElife Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. WAVElife Business Overview
Table 80. WAVElife Recent Developments
Table 81. ProQR Antisense Oligonucleotides (ASO) Drug Basic Information
Table 82. ProQR Antisense Oligonucleotides (ASO) Drug Product Overview
Table 83. ProQR Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. ProQR Business Overview
Table 85. ProQR Recent Developments
Table 86. Exicure Antisense Oligonucleotides (ASO) Drug Basic Information
Table 87. Exicure Antisense Oligonucleotides (ASO) Drug Product Overview
Table 88. Exicure Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Exicure Business Overview
Table 90. Exicure Recent Developments
Table 91. Secarna Antisense Oligonucleotides (ASO) Drug Basic Information
Table 92. Secarna Antisense Oligonucleotides (ASO) Drug Product Overview
Table 93. Secarna Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Secarna Business Overview
Table 95. Secarna Recent Developments
Table 96. AstraZeneca Antisense Oligonucleotides (ASO) Drug Basic Information
Table 97. AstraZeneca Antisense Oligonucleotides (ASO) Drug Product Overview
Table 98. AstraZeneca Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. AstraZeneca Business Overview
Table 100. AstraZeneca Recent Developments
Table 101. The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Basic Information
Table 102. The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Product Overview
Table 103. The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. The WhiteOak Group, Inc. Business Overview
Table 105. The WhiteOak Group, Inc. Recent Developments
Table 106. Dicerna Antisense Oligonucleotides (ASO) Drug Basic Information
Table 107. Dicerna Antisense Oligonucleotides (ASO) Drug Product Overview
Table 108. Dicerna Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Dicerna Business Overview
Table 110. Dicerna Recent Developments
Table 111. Silence Antisense Oligonucleotides (ASO) Drug Basic Information
Table 112. Silence Antisense Oligonucleotides (ASO) Drug Product Overview
Table 113. Silence Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Silence Business Overview
Table 115. Silence Recent Developments
Table 116. Arrowhead Antisense Oligonucleotides (ASO) Drug Basic Information
Table 117. Arrowhead Antisense Oligonucleotides (ASO) Drug Product Overview
Table 118. Arrowhead Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Arrowhead Business Overview
Table 120. Arrowhead Recent Developments
Table 121. Alnylam Antisense Oligonucleotides (ASO) Drug Basic Information
Table 122. Alnylam Antisense Oligonucleotides (ASO) Drug Product Overview
Table 123. Alnylam Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Alnylam Business Overview
Table 125. Alnylam Recent Developments
Table 126. Global Antisense Oligonucleotides (ASO) Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Antisense Oligonucleotides (ASO) Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Antisense Oligonucleotides (ASO) Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Antisense Oligonucleotides (ASO) Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Antisense Oligonucleotides (ASO) Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Antisense Oligonucleotides (ASO) Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Antisense Oligonucleotides (ASO) Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Antisense Oligonucleotides (ASO) Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Antisense Oligonucleotides (ASO) Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Antisense Oligonucleotides (ASO) Drug Market Size Comparison by Region (M USD)
Table 5. Global Antisense Oligonucleotides (ASO) Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Antisense Oligonucleotides (ASO) Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Antisense Oligonucleotides (ASO) Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Oligonucleotides (ASO) Drug as of 2022)
Table 10. Global Market Antisense Oligonucleotides (ASO) Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Antisense Oligonucleotides (ASO) Drug Sales Sites and Area Served
Table 12. Manufacturers Antisense Oligonucleotides (ASO) Drug Product Type
Table 13. Global Antisense Oligonucleotides (ASO) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Antisense Oligonucleotides (ASO) Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Antisense Oligonucleotides (ASO) Drug Market Challenges
Table 22. Global Antisense Oligonucleotides (ASO) Drug Sales by Type (Kilotons)
Table 23. Global Antisense Oligonucleotides (ASO) Drug Market Size by Type (M USD)
Table 24. Global Antisense Oligonucleotides (ASO) Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Type (2019-2024)
Table 26. Global Antisense Oligonucleotides (ASO) Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Antisense Oligonucleotides (ASO) Drug Market Size Share by Type (2019-2024)
Table 28. Global Antisense Oligonucleotides (ASO) Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Antisense Oligonucleotides (ASO) Drug Sales (Kilotons) by Application
Table 30. Global Antisense Oligonucleotides (ASO) Drug Market Size by Application
Table 31. Global Antisense Oligonucleotides (ASO) Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Application (2019-2024)
Table 33. Global Antisense Oligonucleotides (ASO) Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Antisense Oligonucleotides (ASO) Drug Market Share by Application (2019-2024)
Table 35. Global Antisense Oligonucleotides (ASO) Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Antisense Oligonucleotides (ASO) Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Region (2019-2024)
Table 38. North America Antisense Oligonucleotides (ASO) Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Antisense Oligonucleotides (ASO) Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Antisense Oligonucleotides (ASO) Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Antisense Oligonucleotides (ASO) Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Antisense Oligonucleotides (ASO) Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Ionis Antisense Oligonucleotides (ASO) Drug Basic Information
Table 44. Ionis Antisense Oligonucleotides (ASO) Drug Product Overview
Table 45. Ionis Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Ionis Business Overview
Table 47. Ionis Antisense Oligonucleotides (ASO) Drug SWOT Analysis
Table 48. Ionis Recent Developments
Table 49. Novartis Antisense Oligonucleotides (ASO) Drug Basic Information
Table 50. Novartis Antisense Oligonucleotides (ASO) Drug Product Overview
Table 51. Novartis Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Novartis Business Overview
Table 53. Novartis Antisense Oligonucleotides (ASO) Drug SWOT Analysis
Table 54. Novartis Recent Developments
Table 55. Biogen Antisense Oligonucleotides (ASO) Drug Basic Information
Table 56. Biogen Antisense Oligonucleotides (ASO) Drug Product Overview
Table 57. Biogen Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Biogen Antisense Oligonucleotides (ASO) Drug SWOT Analysis
Table 59. Biogen Business Overview
Table 60. Biogen Recent Developments
Table 61. Akcea Antisense Oligonucleotides (ASO) Drug Basic Information
Table 62. Akcea Antisense Oligonucleotides (ASO) Drug Product Overview
Table 63. Akcea Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Akcea Business Overview
Table 65. Akcea Recent Developments
Table 66. Therapeutics Antisense Oligonucleotides (ASO) Drug Basic Information
Table 67. Therapeutics Antisense Oligonucleotides (ASO) Drug Product Overview
Table 68. Therapeutics Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Therapeutics Business Overview
Table 70. Therapeutics Recent Developments
Table 71. Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Basic Information
Table 72. Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Product Overview
Table 73. Sarepta Therapeutics Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Sarepta Therapeutics Business Overview
Table 75. Sarepta Therapeutics Recent Developments
Table 76. WAVElife Antisense Oligonucleotides (ASO) Drug Basic Information
Table 77. WAVElife Antisense Oligonucleotides (ASO) Drug Product Overview
Table 78. WAVElife Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. WAVElife Business Overview
Table 80. WAVElife Recent Developments
Table 81. ProQR Antisense Oligonucleotides (ASO) Drug Basic Information
Table 82. ProQR Antisense Oligonucleotides (ASO) Drug Product Overview
Table 83. ProQR Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. ProQR Business Overview
Table 85. ProQR Recent Developments
Table 86. Exicure Antisense Oligonucleotides (ASO) Drug Basic Information
Table 87. Exicure Antisense Oligonucleotides (ASO) Drug Product Overview
Table 88. Exicure Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Exicure Business Overview
Table 90. Exicure Recent Developments
Table 91. Secarna Antisense Oligonucleotides (ASO) Drug Basic Information
Table 92. Secarna Antisense Oligonucleotides (ASO) Drug Product Overview
Table 93. Secarna Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Secarna Business Overview
Table 95. Secarna Recent Developments
Table 96. AstraZeneca Antisense Oligonucleotides (ASO) Drug Basic Information
Table 97. AstraZeneca Antisense Oligonucleotides (ASO) Drug Product Overview
Table 98. AstraZeneca Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. AstraZeneca Business Overview
Table 100. AstraZeneca Recent Developments
Table 101. The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Basic Information
Table 102. The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Product Overview
Table 103. The WhiteOak Group, Inc. Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. The WhiteOak Group, Inc. Business Overview
Table 105. The WhiteOak Group, Inc. Recent Developments
Table 106. Dicerna Antisense Oligonucleotides (ASO) Drug Basic Information
Table 107. Dicerna Antisense Oligonucleotides (ASO) Drug Product Overview
Table 108. Dicerna Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Dicerna Business Overview
Table 110. Dicerna Recent Developments
Table 111. Silence Antisense Oligonucleotides (ASO) Drug Basic Information
Table 112. Silence Antisense Oligonucleotides (ASO) Drug Product Overview
Table 113. Silence Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Silence Business Overview
Table 115. Silence Recent Developments
Table 116. Arrowhead Antisense Oligonucleotides (ASO) Drug Basic Information
Table 117. Arrowhead Antisense Oligonucleotides (ASO) Drug Product Overview
Table 118. Arrowhead Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Arrowhead Business Overview
Table 120. Arrowhead Recent Developments
Table 121. Alnylam Antisense Oligonucleotides (ASO) Drug Basic Information
Table 122. Alnylam Antisense Oligonucleotides (ASO) Drug Product Overview
Table 123. Alnylam Antisense Oligonucleotides (ASO) Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Alnylam Business Overview
Table 125. Alnylam Recent Developments
Table 126. Global Antisense Oligonucleotides (ASO) Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 127. Global Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 128. North America Antisense Oligonucleotides (ASO) Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 129. North America Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 130. Europe Antisense Oligonucleotides (ASO) Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 131. Europe Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 132. Asia Pacific Antisense Oligonucleotides (ASO) Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 133. Asia Pacific Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 134. South America Antisense Oligonucleotides (ASO) Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 135. South America Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 136. Middle East and Africa Antisense Oligonucleotides (ASO) Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 137. Middle East and Africa Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 138. Global Antisense Oligonucleotides (ASO) Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 139. Global Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 140. Global Antisense Oligonucleotides (ASO) Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 141. Global Antisense Oligonucleotides (ASO) Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 142. Global Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Antisense Oligonucleotides (ASO) Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antisense Oligonucleotides (ASO) Drug Market Size (M USD), 2019-2030
Figure 5. Global Antisense Oligonucleotides (ASO) Drug Market Size (M USD) (2019-2030)
Figure 6. Global Antisense Oligonucleotides (ASO) Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antisense Oligonucleotides (ASO) Drug Market Size by Country (M USD)
Figure 11. Antisense Oligonucleotides (ASO) Drug Sales Share by Manufacturers in 2023
Figure 12. Global Antisense Oligonucleotides (ASO) Drug Revenue Share by Manufacturers in 2023
Figure 13. Antisense Oligonucleotides (ASO) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Antisense Oligonucleotides (ASO) Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Antisense Oligonucleotides (ASO) Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Antisense Oligonucleotides (ASO) Drug Market Share by Type
Figure 18. Sales Market Share of Antisense Oligonucleotides (ASO) Drug by Type (2019-2024)
Figure 19. Sales Market Share of Antisense Oligonucleotides (ASO) Drug by Type in 2023
Figure 20. Market Size Share of Antisense Oligonucleotides (ASO) Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Antisense Oligonucleotides (ASO) Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Antisense Oligonucleotides (ASO) Drug Market Share by Application
Figure 24. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Application in 2023
Figure 26. Global Antisense Oligonucleotides (ASO) Drug Market Share by Application (2019-2024)
Figure 27. Global Antisense Oligonucleotides (ASO) Drug Market Share by Application in 2023
Figure 28. Global Antisense Oligonucleotides (ASO) Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Antisense Oligonucleotides (ASO) Drug Sales Market Share by Country in 2023
Figure 32. U.S. Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Antisense Oligonucleotides (ASO) Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Antisense Oligonucleotides (ASO) Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Antisense Oligonucleotides (ASO) Drug Sales Market Share by Country in 2023
Figure 37. Germany Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Antisense Oligonucleotides (ASO) Drug Sales Market Share by Region in 2023
Figure 44. China Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Antisense Oligonucleotides (ASO) Drug Sales Market Share by Country in 2023
Figure 51. Brazil Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Antisense Oligonucleotides (ASO) Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Antisense Oligonucleotides (ASO) Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Antisense Oligonucleotides (ASO) Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Antisense Oligonucleotides (ASO) Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Antisense Oligonucleotides (ASO) Drug Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Antisense Oligonucleotides (ASO) Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Antisense Oligonucleotides (ASO) Drug Market Size (M USD), 2019-2030
Figure 5. Global Antisense Oligonucleotides (ASO) Drug Market Size (M USD) (2019-2030)
Figure 6. Global Antisense Oligonucleotides (ASO) Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Antisense Oligonucleotides (ASO) Drug Market Size by Country (M USD)
Figure 11. Antisense Oligonucleotides (ASO) Drug Sales Share by Manufacturers in 2023
Figure 12. Global Antisense Oligonucleotides (ASO) Drug Revenue Share by Manufacturers in 2023
Figure 13. Antisense Oligonucleotides (ASO) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Antisense Oligonucleotides (ASO) Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Antisense Oligonucleotides (ASO) Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Antisense Oligonucleotides (ASO) Drug Market Share by Type
Figure 18. Sales Market Share of Antisense Oligonucleotides (ASO) Drug by Type (2019-2024)
Figure 19. Sales Market Share of Antisense Oligonucleotides (ASO) Drug by Type in 2023
Figure 20. Market Size Share of Antisense Oligonucleotides (ASO) Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Antisense Oligonucleotides (ASO) Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Antisense Oligonucleotides (ASO) Drug Market Share by Application
Figure 24. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Application in 2023
Figure 26. Global Antisense Oligonucleotides (ASO) Drug Market Share by Application (2019-2024)
Figure 27. Global Antisense Oligonucleotides (ASO) Drug Market Share by Application in 2023
Figure 28. Global Antisense Oligonucleotides (ASO) Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Antisense Oligonucleotides (ASO) Drug Sales Market Share by Country in 2023
Figure 32. U.S. Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Antisense Oligonucleotides (ASO) Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Antisense Oligonucleotides (ASO) Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Antisense Oligonucleotides (ASO) Drug Sales Market Share by Country in 2023
Figure 37. Germany Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Antisense Oligonucleotides (ASO) Drug Sales Market Share by Region in 2023
Figure 44. China Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Antisense Oligonucleotides (ASO) Drug Sales Market Share by Country in 2023
Figure 51. Brazil Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Antisense Oligonucleotides (ASO) Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Antisense Oligonucleotides (ASO) Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Antisense Oligonucleotides (ASO) Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Antisense Oligonucleotides (ASO) Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Antisense Oligonucleotides (ASO) Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Antisense Oligonucleotides (ASO) Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Antisense Oligonucleotides (ASO) Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Antisense Oligonucleotides (ASO) Drug Market Share Forecast by Application (2025-2030)
